Market Overview

UPDATE: Stifel Nicolaus Raises PT to $36 on DeVry Following FQ2 Earnings

Share:
Related DV
Barron's Picks And Pans: Trump Stocks, Thermo Fisher, Discover And More
Stocks Hitting 52-Week Highs

Stifel Nicolaus reiterated its Buy rating on DeVry (NYSE: DV) and raised the price target from $30.00 to $36.00.

Stifel Nicolaus noted, "DeVry's “transition year” is generally progressing better than expected – beating on revenue, EPS, medical volume metrics, and cost reductions. Expense shift (especially in advertising) to 2H benefited 2Q, but total costs are now expected to be down for the year. Enrollment turn at DeVry University will take time (new enrollment probably does not turn positive by year end) with 2014-2016 targeted as recovery and growth phase. We believe DV is well positioned over the intermediate/long term with focus on high demand programs (medical/technical) and solid value proposition."

DeVry closed at $26.12 on Wednesday.

Latest Ratings for DV

DateFirmActionFromTo
Dec 2016Standpoint ResearchDowngradesBuyHold
Nov 2016Credit SuisseUpgradesNeutralOutperform
Sep 2016Barrington ResearchUpgradesMarket PerformOutperform

View More Analyst Ratings for DV
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Analyst Ratings

 

Related Articles (DV)

View Comments and Join the Discussion!